Drug failures often occur through drug-drug interactions involving cytochrome P450s, especially CYP3A4. Designing safer drugs faster requires a sensitive, easy to use technology that can be used for a broad range of applications. Promega's new P450-Glo 3A4 Assay with Luciferin-IPA delivers: